Results 121 to 130 of about 173,850 (199)

Proinflammatory and cytotoxic CD38⁺HLA-DR⁺ effector memory CD8⁺ T cells are peripherally expanded in human cardiac allograft vasculopathy. [PDF]

Am J Transplant
Tada Y, Suthahar SSA, Roy P, Suryawanshi V, Wu R, Wang E, Nettersheim FS, Bellapu A, Dobaczewska K, Kim C, Vaida F, Morris GP, Ley K, Kim PJ.   +13 more
europepmc   +1 more source

Association of <i>HLA-B</i> and <i>HLA-DR</i> gene polymorphisms with rheumatoid arthritis: A cross-sectional study in Yunnan Chinese Han population. [PDF]

Rheumatol Immunol Res
Dong J, Yang Y, Mo M, Liu S, Bai R, Li S, Zhao R, Xu X, Cheng Y, Xu J.   +9 more
europepmc   +1 more source

Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines. [PDF]

Clin Epigenetics
Humphries S, Burnard SM, Eggins CD, Keely S, Bond DR, Lee HJ.   +5 more
europepmc   +1 more source

CAR-T cells with the CD38^-CD73^-Tim-3^-HLA-DR⁺ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL. [PDF]

Cell Rep Med
Mikami T, Kato I, Llamas-Covarrubias MA, Hiramatsu H, Uchihara Y, Mitsuyoshi T, Kitawaki T, Saida S, Umeda K, Ogawa S, Takaori-Kondo A, Wing JB, Takita J.   +12 more
europepmc   +1 more source

Establishing Reference Values for Peripheral Blood Neutrophil CD64 index and Monocyte HLA-DR of Healthy Adult

Zhang L, Li Y, Zhong H, Huang J, Yin M.
europepmc   +1 more source

Validation of an Automated Cell Counter Method for HLA-DR and CD3 Expression in Cells Obtained from Low Volume Human Tears. [PDF]

Diagnostics (Basel)
Ciavarella C, Astolfi A, Coslovi C, Potenza M, Pasquinelli G, Fontana L, Versura P.   +6 more
europepmc   +1 more source

New light on the HLA-DR immunopeptidomic landscape. [PDF]

J Leukoc Biol
Egholm Bruun Jensen E, Reynisson B, Barra C, Nielsen M.   +3 more
europepmc   +1 more source

ASSOCIATION OF HLA COMPATIBILITY AND DECREASED LIVER-TRANSPLANT SURVIVAL [PDF]

, 1988
BRYAN, C, DUQUESNOY, RJ, FUNG, JJ, GORDON, RD, KLINTMALM, G, MARKUS, BH, STARZL, TE, VANEK, M, VANTHIEL, D   +8 more
core  

Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples.

J Pharm Bioallied Sci
Ilyas M, Singh A, Gupta PP, Saad T, Singh P, Mishra S, Asati A.   +6 more
europepmc   +1 more source

CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies. [PDF]

Sci Rep
Aakko S, Ylitalo A, Kuusanmäki H, Rannikko JH, Björkman M, Mandelin J, Heckman CA, Kontro M, Hollmén M.   +8 more
europepmc   +1 more source